Tilray Medical Publishes Pioneering Research on the Pharmacokinetics of THC and CBD Formulations

Image for article Tilray Medical Publishes Pioneering Research on the Pharmacokinetics of THC and CBD Formulations
News Source : Financial Post

News Summary

  • New Study Provides Insight into the Bioavailability of Medical Cannabis Formulations for Therapeutic Treatment
  • The study aimed to assess the pharmacokinetic parameters and relative bioavailability of two D9-tetrahydrocannabinol: cannabidiol (THC:CBD) formulations
  • The findings may have significant implications for clinical populations using these formulations therapeutically
Tilray Medical is a leading provider of EUGMP certified and pharmaceuticalgrade medical cannabis products, having supplied over 20 countries with a comprehensive portfolio of THC and CBD products. [+4409 chars]

Must read Articles